Nuclear exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding

被引:42
作者
Bennett, Ryan P. [1 ]
Presnyak, Vladimir [1 ]
Wedekind, Joseph E. [1 ]
Smith, Harold C. [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Biochem, Rochester, NY 14642 USA
关键词
D O I
10.1074/jbc.M708567200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human APOBEC3G ( hA3G) is a host factor that defends against HIV-1 as well as other exogenous retroviruses and endogenous retroelements. To this end, hA3G is restricted to the cytoplasm of T lymphocytes where it interacts with viral RNA and proteins to assemble with viral particles causing a post-entry block during reverse transcription. hA3G also exhibits a mechanism to inhibit the reverse transcription of retroelements by RNA binding and sequestration into mRNA processing centers in the cytoplasm. We have determined that the molecular basis for this specialized property of hA3G is a novel cytoplasmic retention signal ( CRS) that is necessary and sufficient to restrict wild-type hA3G and chimeric constructs to the cytoplasm. The CRS resides within amino acids 113-128 and is embedded within a basic flanking sequence and does not require RNA binding to retain hA3G in the cytoplasm. Paralogs of hA3G that have nuclear or cytoplasmic distributions differ from hA3G within the region encompassing the CRS motif with respect to charge and amino acid composition. We propose that the CRS enables hA3G to interact with cytoplasmic factors, and thereby enables hA3G to serve in host cell defense by restricting an antiviral sentinel to the cytoplasm. The CRS lies in a region involved in both Gag and Vif interactions; therefore, identification of this motif has important implications for the design of therapeutics that target HIV-1 while maintaining antiviral and cellular functions.
引用
收藏
页码:7320 / 7327
页数:8
相关论文
共 79 条
[1]   APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein [J].
Alce, TM ;
Popik, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34083-34086
[2]   Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines [J].
Babbage, G ;
Ottensmeier, CH ;
Blaydes, J ;
Stevenson, FK ;
Sahota, SS .
CANCER RESEARCH, 2006, 66 (08) :3996-4000
[3]   C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion [J].
Barreto, V ;
Reina-San-Martin, B ;
Ramiro, AR ;
McBride, KM ;
Nussenzweig, MC .
MOLECULAR CELL, 2003, 12 (02) :501-508
[4]   APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic [J].
Bennett, Ryan P. ;
Diner, Elie ;
Sowden, Mark P. ;
Lees, Joshua A. ;
Wedekind, Joseph E. ;
Smith, Harold C. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (01) :214-219
[5]   Antiviral potency of APOBEC proteins does not correlate with cytidine deamination [J].
Bishop, Kate N. ;
Holmes, Rebecca K. ;
Malim, Michael H. .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8450-8458
[6]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[7]   APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells [J].
Bogerd, HP ;
Wiegand, HL ;
Doehle, BP ;
Lueders, KK ;
Cullen, BR .
NUCLEIC ACIDS RESEARCH, 2006, 34 (01) :89-95
[8]   Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks [J].
Brar, SS ;
Watson, M ;
Diaz, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26395-26401
[9]   APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC linker [J].
Burnett, Atuhani ;
Spearman, Paul .
JOURNAL OF VIROLOGY, 2007, 81 (10) :5000-5013
[10]   The interaction between HIV-1 Gag and APOBEC3G [J].
Cen, S ;
Guo, F ;
Niu, MJ ;
Saadatmand, J ;
Deflassieux, J ;
Kleiman, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33177-33184